Cardiovascular correlates of insulin resistance in normotensive and hypertensive African Americans

Metabolism: Clinical and Experimental

Volumn 60, Issue 6, 2011, Pages 835-842

  Kidambi, Srividya ^a,b   Kotchen, Jane M ^a   Krishnaswami, Shanthi ^a   Grim, Clarence E ^a   Kotchen, Theodore A ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b CLEMENT J ZABLOCKI VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE; CHOLESTEROL; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AFRICAN AMERICAN; ALDOSTERONE BLOOD LEVEL; ANTHROPOMETRY; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; FEMALE; GLUCOSE BLOOD LEVEL; HEART OUTPUT; HEART RATE; HEART STROKE VOLUME; HUMAN; HYPERTENSION; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; PRIORITY JOURNAL; SYSTOLIC BLOOD PRESSURE;

ADOLESCENT; ADULT; AFRICAN AMERICANS; ALDOSTERONE; BLOOD GLUCOSE; BLOOD PRESSURE; CARDIAC OUTPUT; CARDIOVASCULAR PHYSIOLOGICAL PHENOMENA; DIABETES MELLITUS, TYPE 2; FEMALE; HEART RATE; HUMANS; HYPERTENSION; INSULIN; INSULIN RESISTANCE; LINEAR MODELS; MALE; MIDDLE AGED; NOREPINEPHRINE; OBESITY; STRESS, PSYCHOLOGICAL; STROKE VOLUME; VASOCONSTRICTOR AGENTS; YOUNG ADULT;

EID: 79956141428     PISSN: 00260495     EISSN: 15328600     Source Type: Journal    
DOI: 10.1016/j.metabol.2010.07.036     Document Type: Article

References (40)

1. Razani B, Chakravarthy MV, Semenkovich CF. Insulin resistance and atherosclerosis. Endocrinol Metab Clin North Am. 2008;37:603-21, viii.
2. Gaillard T, Schuster D, Osei K. Metabolic syndrome in black people of the African diaspora: the paradox of current classification, definition and criteria. Ethn Dis 2009;19(2 Suppl 2):S2-1-7.
3. Saad MF, Rewers M, Selby J, Howard G, Jinagouda S, Fahmi S, et al. Insulin resistance and hypertension: the Insulin Resistance Atherosclerosis study. Hypertension 2004;43:1324-31. (Pubitemid 38691757)
4. Kidambi S, Kotchen JM, Krishnaswami S, Grim CE, Kotchen TA. Aldosterone contributes to blood pressure variance and to likelihood of hypertension in normal-weight and overweight African Americans. Am J Hypertens 2009;22:1303-8.
5. Muniyappa R, Montagnani M, Koh KK, Quon MJ. Cardiovascular actions of insulin. Endocr Rev 2007;28:463-91. (Pubitemid 47236334)
6. Muniyappa R, Iantorno M, Quon MJ. An integrated view of insulin resistance and endothelial dysfunction. Endocrinol Metab Clin North Am 2008;37:685-711, ix-x.
7. Deng JY, Huang JP, Lu LS, Hung LM. Impairment of cardiac insulin signaling and myocardial contractile performance in high-cholesterol/fructose- fed rats. Am J Physiol Heart Circ Physiol 2007;293:H978-87.
8. Raher MJ, Thibault HB, Buys ES, Kuruppu D, Shimizu N, Brownell AL, et al. A short duration of high-fat diet induces insulin resistance and predisposes to adverse left ventricular remodeling after pressure overload. Am J Physiol Heart Circ Physiol 2008;295:H2495-502.
9. Govindarajan G, Hayden MR, Cooper SA, Figueroa SD, Ma L, Hoffman TJ, et al. Metabolic derangements in the insulin-resistant heart. J Cardiometab Syndr 2006;1:102-6.
10. Peterson LR. Obesity and insulin resistance: effects on cardiac structure, function, and substrate metabolism. Curr Hypertens Rep 2006;8:451-6. (Pubitemid 44842770)
11. Nigro J, Osman N, Dart AM, Little PJ. Insulin resistance and atherosclerosis. Endocr Rev 2006;27:242-59.
12. Kearney MT, Duncan ER, Kahn M, Wheatcroft SB. Insulin resistance and endothelial cell dysfunction: studies in mammalian models. Exp Physiol 2008;93:158-63. (Pubitemid 350293975)
13. Frisbee JC. Obesity, insulin resistance, and microvessel density. Microcirculation 2007;14:289-98. (Pubitemid 47050022)
14. Balletshofer BM, Rittig K, Stock J, Lehn-Stefan A, Overkamp D, Dietz K, et al. Insulin resistant young subjects at risk of accelerated atherosclerosis exhibit a marked reduction in peripheral endothelial function early in life but not differences in intima-media thickness. Atherosclerosis 2003;171:303-9. (Pubitemid 37486083)
15. Suzuki M, Takamisawa I, Suzuki K, Hiuge A, Horio T, Yoshimasa Y, et al. Close association of endothelial dysfunction with insulin resistance and carotid wall thickening in hypertension. Am J Hypertens 2004;17:228-32. (Pubitemid 38293327)
16. Kidambi S, Kotchen JM, Grim CE, Raff H, Mao J, Singh RJ, et al. Association of adrenal steroids with hypertension and the metabolic syndrome in blacks. Hypertension 2007;49:704-11.
17. Kidambi S, Kotchen JM, Krishnaswami S, Grim CE, Kotchen TA. Hypertension, insulin resistance, and aldosterone: sex-specific relationships. J Clin Hypertens (Greenwich) 2009;11:130-7.
18. Kotchen TA, Kotchen JM, Grim CE, Krishnaswami S, Kidambi S. Aldosterone and alterations of hypertension-related vascular function in African Americans. Am J Hypertens 2009;22:319-24.
19. Homa Calculator v 2.2.2. [cited 2007 Dec 26, 2007]; v 2.2.2:[Available from: www.dtu.ox.ac.uk.
20. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 2002;39 (2 Suppl 1):S1-S266.
21. Grim CE, Cowley Jr AW, Hamet P, Gaudet D, Kaldunski ML, Kotchen JM, et al. Hyperaldosteronism and hypertension: ethnic differences. Hypertension 2005;45:766-72.
22. Scotland R, Vallance P, Ahluwalia A. Endothelin alters the reactivity of vasa vasorum: mechanisms and implications for conduit vessel physiology and pathophysiology. Br J Pharmacol 1999;128:1229-34.
23. Cusi K, Maezono K, Osman A, Pendergrass M, Patti ME, Pratipanawatr T, et al. Insulin resistance differentially affects the PI 3-kinase- and MAP kinase-mediated signaling in human muscle. J Clin Invest 2000;105:311-20. (Pubitemid 30094451)
24. Jialal I, Crettaz M, Hachiya HL, Kahn CR, Moses AC, Buzney SM, et al. Characterization of the receptors for insulin and the insulin-like growth factors on micro- and macrovascular tissues. Endocrinology 1985;117:1222-9. (Pubitemid 15020055)
25. Bar RS, Kahn CR, Koren HS. Insulin inhibition of antibody-dependent cytoxicity and insulin receptors in macrophages. Nature 1977;265:632-5. (Pubitemid 8034090)
26. Zoppini G, Galante P, Zardini M, Muggeo M. Phosphotyrosine protein profiles in monocytes after insulin and IGF-1 stimulation. Eur J Clin Invest 1994;24:275-8. (Pubitemid 24204967)
27. Helderman JH. Acute regulation of human lymphocyte insulin receptors. Analysis by the glucose clamp. J Clin Invest 1984;74:1428-35.
28. Joly L, Perret-Guillaume C, Kearney-Schwartz A, Salvi P, Mandry D, Marie PY, et al. Pulse wave velocity assessment by external noninvasive devices and phase-contrast magnetic resonance imaging in the obese. Hypertension 2009;54:421-6.
29. Anderson EA, Hoffman RP, Balon TW, Sinkey CA, Mark AL. Hyperinsulinemia produces both sympathetic neural activation and vasodilation in normal humans. J Clin Invest 1991;87:2246-52.
30. Lembo G, Napoli R, Capaldo B, Rendina V, Iaccarino G, Volpe M, et al. Abnormal sympathetic overactivity evoked by insulin in the skeletal muscle of patients with essential hypertension. J Clin Invest 1992;90:24-9.
31. Rowe JW, Young JB, Minaker KL, Stevens AL, Pallotta J, Landsberg L. Effect of insulin and glucose infusions on sympathetic nervous system activity in normal man. Diabetes 1981;30:219-25. (Pubitemid 11026317)
32. Grassi G, Arenare F, Quarti-Trevano F, Seravalle G, Mancia G. Heart rate, sympathetic cardiovascular influences, and the metabolic syndrome. Prog Cardiovasc Dis 2009;52:31-7.
33. Potenza MA, Marasciulo FL, Chieppa DM, Brigiani GS, Formoso G, Quon MJ, et al. Insulin resistance in spontaneously hypertensive rats is associated with endothelial dysfunction characterized by imbalance between NO and ET-1 production. Am J Physiol Heart Circ Physiol 2005;289:H813-22.
34. Buell JC. A practical, cost-effective, noninvasive system for cardiac output and hemodynamic analysis. Am Heart J 1988;116(2 Pt 2):657-64.
35. Brown CV, Martin MJ, Shoemaker WC, Wo CC, Chan L, Azarow K, et al. The effect of obesity on bioimpedance cardiac index. Am J Surg 2005;189:547-50 [discussion 50-1].
36. Atallah MM, Demain AD. Cardiac output measurement: lack of agreement between thermodilution and thoracic electric bioimpedance in two clinical settings. J Clin Anesth 1995;7:182-5.
37. Doering L, Lum E, Dracup K, Friedman A. Predictors of between-method differences in cardiac output measurement using thoracic electrical bioimpedance and thermodilution. Crit Care Med 1995;23:1667-73.
38. Zacek P, Kunes P, Kobzova E, Dominik J. Thoracic electrical bioimpedance versus thermodilution in patients post open-heart surgery. Acta Medica (Hradec Kralove) 1999;42:19-23.
39. Mensah GA, Mokdad AH, Ford ES, Greenlund KJ, Croft JB. State of disparities in cardiovascular health in the United States. Circulation 2005;111:1233-41. (Pubitemid 40389086)
40. Jamerson KA. Preventing chronic kidney disease in special populations. Am J Hypertens 2005;18(4 Pt 2):106S-11S.